621TiP BNT323-03: A phase I/II trial of BNT323/DB-1303 (HER2 ADC) with BNT327 (PD-L1 x VEGF-A) in patients (pts) with advanced breast cancer (BC). - Modi, S.; Ates, O.; Baird, R.D.; Bulat, I.V.; Moreno Candilejo, I.; Curigliano, G.; Dalenc, F.; Jerzak, K.; Maglakelidze, M.; Savas, P.; Wenger, M.; Brück, P.; et al. (Annals of Oncology, 2025)